Clinical Trial Update: Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tralokinumab for atopic dermatitis and its effects on skin barrier function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: Prof. Dr. Stephan Weidinger | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED